Related Experiment Video
Updated: Apr 21, 2026

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans
Published on: December 19, 2014
Central nervous system cryptococcoma in a Ugandan patient with Human Immunodeficiency Virus
Sruti S Velamakanni1, Nathan C Bahr2, Abdu K Musubire3
1Infectious Disease Institute, Makerere University, Kampala, Uganda ; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
AIDS-related Cryptococcal meningitis (CM) has high mortality in low-income countries. This study highlights cryptococcoma, a serious complication, and its management challenges in resource-limited settings.
Area of Science:
- Neuroscience
- Infectious Diseases
- Public Health
Background:
- AIDS-related Cryptococcal meningitis (CM) causes over 50% mortality in low-middle income countries.
- Disseminated CM can lead to cryptococcomas, intracranial mass lesions associated with poorer patient outcomes.
- Cryptococcomas present unique diagnostic and management challenges, particularly in resource-limited settings.
Purpose of the Study:
- To describe a case of central nervous system (CNS) cryptococcoma in a Ugandan patient with AIDS.
- To review the diagnosis and management of CNS cryptococcomas.
- To highlight the specific difficulties in diagnosing and managing cryptococcomas in low and middle-income countries (LMICs).
Main Methods:
- Case report of a Ugandan patient with AIDS presenting with CNS cryptococcoma.
- Literature review focusing on diagnosis and management strategies for cryptococcomas.
- Analysis of challenges faced in LMICs for managing this condition.
Main Results:
- Detailed description of a CNS cryptococcoma case in an AIDS patient.
- Identification of diagnostic and therapeutic hurdles in LMICs, including limited imaging and antifungal availability.
- Emphasis on the poorer prognosis associated with cryptococcomas compared to non-cryptococcoma cryptococcosis.
Conclusions:
- Cryptococcomas represent a severe complication of Cryptococcal meningitis in AIDS patients.
- Effective management in LMICs is hampered by resource limitations, necessitating tailored strategies.
- Improved diagnostic tools and accessible treatments are crucial for better outcomes in affected populations.
Related Concept Videos
Cytomegalovirus Disease
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Sexually Transmitted Infections

